Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons

Hormones and Behavior

Volumn 59, Issue 4, 2011, Pages 503-511

  Gibbs, R B ^a   Chipman, A M ^a   Nelson, D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

192IgG saporin; Alzheimer's disease; Cholinergic lesion; Cholinesterase inhibitor; Critical period hypothesis; Hormone therapy; Mild cognitive impairment; Perseveration; Spatial learning; Surgical menopause

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DONEPEZIL; ESTRADIOL; KETOPROFEN; SAPORIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; HIPPOCAMPUS; LEARNING; MAZE TEST; MENTAL PERFORMANCE; NERVE CELL LESION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; WORKING MEMORY;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; ESTRADIOL; ESTROGENS; FEMALE; INDANS; MAZE LEARNING; MEMORY; NEURONS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEPTUM OF BRAIN;

EID: 79954913086     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.01.011     Document Type: Article

References (54)

1. Aggarwal P., Gibbs R.B. Estrogen replacement does not prevent the loss of choline acetyltransferase-positive cells in the basal forebrain following either neurochemical or mechanical lesions. Brain Res. 2000, 882:75-85.
2. Baskerville K.A., Kent C., Nicolle M.M., Gallagher M., McKinney M. Aging causes partial loss of basal forebrain but no loss of pontine reticular cholinergic neurons. NeuroReport 2006, 17:1819-1823.
3. Carriere I., Fourrier-Reglat A., Dartigues J.F., Rouaud O., Pasquier F., Ritchie K., Ancelin M.L. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch. Intern. Med. 2009, 169:1317-1324.
4. Coker L.H., Espeland M.A., Rapp S.R., Legault C., Resnick S.M., Hogan P., Gaussoin S., Dailey M., Shumaker S.A. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J. Steroid Biochem. Mol. Biol. 2010, 118:304-310.
5. Cutuli D., Foti F., Mandolesi L., De Bartolo P., Gelfo F., Federico F., Petrosini L. Cognitive performances of cholinergically depleted rats following chronic donepezil administration. J. Alzheimers Dis. 2009, 17:161-176.
6. Daniel J.M. Effects of oestrogen on cognition: what have we learned from basic research?. J. Neuroendocrinol. 2006, 18:787-795.
7. Daniel J.M., Dohanich G.P. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J. Neurosci. 2001, 21:6949-6956.
8. Daniel J.M., Hulst J.L., Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006, 147:607-614.
9. Daniel J.M., Hulst J.L., Lee C.D. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience 2005, 132:57-64.
10. Fischer W., Chen K.S., Gage F.H., Bjorklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 1992, 13:9-23.
11. Fitz N.F., Gibbs R.B., Johnson D.A. Selective lesion of septal cholinergic neurons in rats impairs acquisition of a delayed matching to position T-maze task by delaying the shift from a response to a place strategy. Brain Res. Bull. 2008, 77:356-360.
12. Frick K.M. Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?. Horm. Behav. 2009, 55:2-23.
13. Gibbs R. Preclinical data relating to estrogen's effects on cognitive performance. The Effects of Estrogen on Brain Function 2006, 9-45. The Johns Hopkins University Press, Baltimore. N.L. Rasgon (Ed.).
14. Gibbs R.B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 1998, 151:289-302.
15. Gibbs R.B. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm. Behav. 1999, 36:222-233.
16. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101:931-938.
17. Gibbs R.B. Basal forebrain cholinergic neurons are necessary for estrogen to enhance acquisition of a delayed matching-to-position T-maze task. Horm. Behav. 2002, 42:245-257.
18. Gibbs R.B. Effects of ageing and long-term hormone replacement on cholinergic neurones in the medial septum and nucleus basalis magnocellularis of ovariectomized rats. J. Neuroendocrinol. 2003, 15:477-485.
19. Gibbs R.B. Estradiol enhances DMP acquisition via a mechanism not mediated by turning strategy but which requires intact basal forebrain cholinergic projections. Horm. Behav. 2007, 52:352-359.
20. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 2010, 31:224-253.
21. Gibbs R.B., Gabor R., Cox T., Johnson D.A. Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat. Psychoneuroendocrinology 2004, 29:741-748.
22. Gibbs R.B., Johnson D.A. Cholinergic lesions produce task-selective effects on delayed matching to position and configural association learning related to response pattern and strategy. Neurobiol. Learn. Mem. 2007, 88:19-32.
23. Gibbs R.B., Mauk R., Nelson D., Johnson D.A. Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis. Horm. Behav. 2009, 56:73-83.
24. Hammond R., Mauk R., Ninaci D., Nelson D., Gibbs R.B. Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats. Horm. Behav. 2009, 56:309-314.
25. Henderson V.W. The critical window hypothesis: hormone exposures and cognitive outcomes after menopause. Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies 2009, 131-177. Cambridge University Press, Cambridge, UK. E. Hogervorst (Ed.).
26. Henderson V.W., PaganiniHill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R. Estrogen for Alzheimer's disease in women-randomized, double-blind, placebo-controlled trial. Neurology 2000, 54:295-301.
27. Johnson D.A., Zambon N.J., Gibbs R.B. Selective lesion of cholinergic neurons in the medial septum by 192 IgG-saporin impairs learning in a delayed matching to position T-maze paradigm. Brain Res. 2002, 943:132-141.
28. Kim H.J., Casadesus G. Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us?. Biochim. Biophys. Acta 2010, 1800:1090-1093.
29. Lam T.T., Leranth C. Role of the medial septum diagonal band of Broca cholinergic neurons in oestrogen-induced spine synapse formation on hippocampal CA1 pyramidal cells of female rats. Eur. J. Neurosci. 2003, 17:1997-2005.
30. Lanari A., Amenta F., Silvestrelli G., Tomassoni D., Parnetti L. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mech. Ageing Dev. 2006, 127:158-165.
31. Linstow E.v., Platt B. Biochemical dysfunction and memory loss: the case of Alzheimer's dementia. Cell. Mol. Life Sci. 1999, 55:601-616.
32. Luine V.N. Sex steroids and cognitive function. J. Neuroendocrinol. 2008, 20:866-872.
33. Markowska A.L., Savonenko A.V. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J. Neurosci. 2002, 22:10985-10995.
34. Mesulam M.M. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog. Brain Res. 1996, 109:285-297.
35. Mulnard R.A., Corrada M.M., Kawas C.H. Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment. Curr. Neurol. Neurosci. Rep. 2004, 4:368-373.
36. Mulnard R.A., Cotman C.W., Kawas C., Dyck C.H.v., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 2000, 283:1007-1015.
37. Nebes R.D., Pollock B.G., Halligan E.M., Houck P., Saxton J.A. Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use. Am. J. Geriatr. Psychiatry 2010.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Atlas 1986, Academic Press, London.
39. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener. Dis. 2010, 7:163-166.
40. Rudick C.N., Gibbs R.B., Woolley C.S. A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells. J. Neurosci. 2003, 23:4479-4490.
41. Sapronov N.S., Fedotova Y.O., Kuznetsova N.N. Antiamnestic effect of alpha7-nicotinic receptor agonist RJR-2403 in middle-aged ovariectomized rats with Alzheimer type dementia. Bull. Exp. Biol. Med. 2006, 142:700-702.
42. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996, 46:1580-1584.
43. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat. Rev. Endocrinol. 2009, 5:620-627.
44. Smith C.C., Vedder L.C., Nelson A.R., Bredemann T.M.., McMahon L.L.. Duration of estrogen deprivation, not chronological age, prevents estrogen's ability to enhance hippocampal synaptic physiology. PNAS 2010, 107:19543-19548.
45. Smith D.E., Roberts J., Gage F.H., Tuszynski M.H. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl Acad. Sci. USA 1999, 96:10893-10898.
46. Smith Y.R., Minoshima S., Kuhl D.E., Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 2001, 86:679-684.
47. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front. Neuroendocrinol. 2008, 29:219-237.
48. Sugimoto H., Ogura H., Arai Y., Limura Y., Yamanishi Y. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J. Pharmacol. 2002, 89:7-20.
49. Suzuki S., Brown C.M., Wise P.M. Mechanisms of neuroprotection by estrogen. Endocr. 2006, 29:209-215.
50. Talboom J.S., Williams B.J., Baxley E.R., West S.G., Bimonte-Nelson H.A. Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats. Neurobiol. Learn. Mem. 2008, 90:155-163.
51. Taylor G.T., Maloney S. Gender differences and the role of estrogen in cognitive enhancements with nicotine in rats. Pharmacol. Biochem. Behav. 2010, 95:139-145.
52. Vinogradov S., Fisher M., Warm H., Holland C., Kirshner M.A., Pollock B.G. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am. J. Psychiatry 2009, 166:1055-1062.
53. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 2000, 54:2061-2066.
54. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 1991, 37:475-524.